Analytic Validation of a Next Generation Sequencing Based Primary Immunodeficiency Panel
Apr 24, 2018
Abstract
Genetics diagnostics of patients with suspicion of immunodeficiency has been affected by poorly validated genetic tests, lack of transparency, and testing solutions that are not optimized for maximal diagnostic yield. Our goal was to develop a high quality next generation sequencing (NGS) platform, transparently and comprehensively validate its quality and performance, and report our experiences with hundreds of patients suspected with primary immunodeficiency (PID).
Please be advised that a specimen collection kit must be requested by a medical professional.
If you are a patient or family member of a patient, please contact your provider to place a kit order on your behalf.